21-OHD CAH
21OHD diagnostic reports and evidence domains. The source matrix records whether findings address each domain.
Download CSV AtlasDomain-specific / Insufficient Evidence
| Paper | Year | Study design | Reported sample size | Linked case records | Reported findings | Evidence source |
|---|---|---|---|---|---|---|
| Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of <i>CYP21A2</i> Gene. P001940 | 2024 | Case series; molecular diagnostic study | 3 | — | Molecular testing resolved complex CYP21A2 genotypes. The authors reported concordance with the severe phenotype in the study. | p. 2 source_checked |
| Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report. P002297 | 2022 | Case report | 1 | — | Repeat 17-OHP testing and imaging contributed to diagnosis after an initial non-diagnostic 17-OHP result. | p. 1 source_checked |
| Three out of four: a case discussion on ambiguous genitalia. P001676 | 2008 | Family case report | 3 | — | The report used clinical and biochemical findings to establish a diagnosis. Molecular confirmation was unavailable. | p. 2 source_checked |
| [A case of 21-hydroxylase deficiency and Bartter's syndrome associated with a balanced 6-9 translocation]. P001565 | 1986 | Case report | 1 | — | The report described a dual diagnosis. The accompanying Bartter-like disorder persisted despite treatment for 21OHD. | p. 2 source_checked |
Cite this page
Data version · v1.4.0